All news

Developments and directions in thyroid cancer

Added: Friday 3 May 2013

Dr Steven Sherman gives an update on the current situation with thyroid cancer. He discusses what treatment patients are usually given and mentions recent developments with the use of vandetanib and cabozantinib.

+  http://www.practiceupdate.com/Explore/ExpertOpinion/?id=324&elsca1=emc_enews_expert-insight&elsca2=email&elsca3=practiceupdate_onc&elsca4=oncology&elsca5=newsletter


//